4890 SB (Requip 0.25 mg)
Generic Name: ropinirole
Pill with imprint 4890 SB is White, Five-sided and has been identified as Requip 0.25 mg. It is supplied by GlaxoSmithKline.
Requip is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Requip 0.25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 4890 SB
Requip
- Generic Name
- ropinirole
- Imprint
- 4890 SB
- Strength
- 0.25 mg
- Color
- White
- Size
- 8.00 mm
- Shape
- Five-sided
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- Inactive Ingredients
-
croscarmellose sodium,
lactose monohydrate,
magnesium stearate,
microcrystalline cellulose,
hypromellose 2910 (3 mPa.s),
polyethylene glycol 400,
polysorbate 80,
titanium dioxide,
hypromellose 2910 (6 mPa.s)
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00007-4890 (Discontinued) | GlaxoSmithKline |
| 35356-0522 | Lake Erie Medical and Surgical Supply (repackager) |
More about Requip (ropinirole)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (116)
- Drug images
- Compare alternatives
- En español
- Drug class: dopaminergic antiparkinsonism agents
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.